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Abstract 
Background: The diagnostic value of lung ultrasonography (LUS) and procalcitonin (PCT) in the diagnosis of lung 
infections is known. No studies evaluated the combination of LUS and PCT for the diagnosis of pneumonia in the 
emergency department (ED). We evaluated the diagnostic accuracy of the combination of LUS and PCT in the diag-
nosis of pneumonia.
Methods: Patients with respiratory symptoms of unexplained origin who underwent a chest CT in ED were included 
in the study if PCT assay was available. LUS was performed before CT and was targeted to the detection of lung con-
solidations with the morphologic features of pneumonia. A PCT assay was performed at presentation, and cut-off of 
0.25 and of 0.5 ng/ml were used to rule-out and rule-in pneumonia. The final diagnosis of pneumonia was established 
by independent clinicians, on the basis of clinical chart review including CT results.
Results: We enrolled 128 patients and pneumonia was the final diagnosis in 61 (47.7%). In 38 patients (29.7%) LUS 
and PCT were negative (PCT < 0.25 ng/ml). The overall accuracy, sensitivity and negative predictive value of LUS/PCT 
were 88.8, 96.7 and 94.7% respectively. Sensitivity of the LUS/PCT test was significantly superior to LUS alone (85.2%) 
and PCT alone (73.8%) (p < 0.05 for both). Specificity and positive predictive value of the combination of positivity of 
LUS/PCT (PCT > 0.5 ng/ml) were 94% and 83.3% respectively. Specificity of LUS/PCT was not significantly different to 
LUS alone (88.1%) (p = 0.125).
Conclusions: The sensitivity of the combination of LUS with PCT for the diagnosis of pneumonia was significantly 
superior when compared with the sensitivity of LUS and PCT alone.
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Background
Pneumonia is an infection that involves alveoli, distal 
airways, and interstitium leading to lung inflammatory 
consolidations and is one of the major infection-related 
cause of death in developed countries [1, 2].
The mainstay of the diagnosis is based on symptoms 
and signs consistent with acute infection of the lower 
respiratory tract associated with the visualization of at 
least one pulmonary consolidation at chest imaging. For 
the purpose of imaging the consolidation, chest com-
puted tomography (CT) is the diagnostic gold stand-
ard. Unfortunately CT can’t be used routinely because 
of high cost, radiation exposure and scarce availability 
in low resources settings [3]. Thus, in clinical practice, 
chest radiography (CXR) represents the standard of care 
and is mostly used to diagnose pneumonia. However, in 
patients evaluated in the emergency department (ED), 
CXR showed a poor sensitivity (43.5%) when compared 
to CT [4]. Therefore, reliance on CXR to diagnose pneu-
monia may lead to significant rates of misdiagnosis.
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Lung ultrasonography (LUS) is an emerging bedside 
diagnostic tool with a sensitivity of 94% and a specific-
ity of 96% for the diagnosis of pneumonia according to a 
recent metanalysis [5]. Procalcitonin (PCT) expression in 
parenchymal tissue is induced by bacterial infection and 
its concentrations have been successfully used to diag-
nose and guide antibiotic therapy in lower respiratory 
tract infections [6, 7].
No previous studies have evaluated the accuracy of a 
combination of LUS and PCT for the diagnosis of pneu-
monia in the ED. Thus, the aim of our study was to assess 
the diagnostic accuracy of the combination of LUS with 




This is a prospective accuracy study, in which patients 
enrolled in a registry from December 2011 to August 
2012 were included if PCT level at admission was avail-
able [8]. Patients were recruited in the ED with an annual 
census of 130,000 visits. The study was approved by the 
local institutional review board. Written informed con-
sent was obtained for inclusion in the study.
Consecutive patients aged >18  years with at least one 
unexplained respiratory complaint among dyspnea, 
chest pain, cough or hemoptysis with or without fever, 
for which the attending emergency physician ordered a 
chest CT were considered in the study. PCT was ordered 
by the attending emergency physician, independent from 
the study protocol, when a infective cause was suspected.
Methods
Lung ultrasonography was performed before and within 
3 h from chest CT by one of eight sonographer investiga-
tors who participated to the study. The investigators were 
four internal and emergency medicine staff physicians 
with at least 5  years experience on point-of-care emer-
gency ultrasonography and four resident physicians (two 
in Internal Medicine and two in Emergency Medicine) 
with at least 6 months training in emergency ultrasound. 
The investigators were aware of the presenting symp-
toms and the evident physical signs, but were blinded to 
all the other general clinical information including any 
radiologic finding and laboratory results. The following 
multi-probe machines were used: MyLab30 Gold (Esaote, 
Genova, Italy) and HD7 (Philips, Amsterdam, Holland). 
LUS was performed by using a 4–8 MHz linear probe or 
a 3.5–5 MHz curved array probe. The lung was examined 
by longitudinal and oblique scans on anterior, lateral and 
posterior chest. The patient was preferably examined 
in the sitting position. When this latter position could 
not be maintained, due to critical clinical conditions or 
poor compliance, the examination was performed in the 
supine or semi-recumbent position. The posterior areas 
were scanned in the sitting position or, when not feasible, 
by turning the patient in the lateral decubitus on both 
sides. The LUS examination was targeted to the detec-
tion of typical subpleural lung consolidations with tissue-
like or anechoic pattern and blurred, irregular margins 
with associated focal B-lines [9]. The consolidations due 
to infection usually show dynamic air bronchograms 
(branching echogenic structures with centrifuge move-
ment with breathing) or multiple hyperechogenic lentil-
sized spots, due to air trapped in the small airways. LUS 
was considered positive when at least one consolidation 
showing the above-described features was detected. Pleu-
ral effusion could be associated with consolidation and 
has been interpreted as an auxiliary sign, but its detec-
tion was not considered individually as sign of suspected 
pneumonia.
Chest radiography was performed using a Practix 300 
Bucky diagnostic equipment (Philips Medical Systems, 
Hamburg, Germany) by posterior-anterior and lateral 
views in the upright patients and anterior-posterior view 
in the supine patients, following standardized hospital 
diagnostic protocol. The film was digitally reviewed by an 
expert radiologist blinded to the results of LUS and CT. 
The radiologist had the possibility to review also previ-
ous CXR, when available, as part of standard clinical 
care. The radiologist was asked to detect and locate the 
opacities that might correlate with the diagnosis of pneu-
monia. CXR was considered positive when at least one 
typical consolidation was visualized.
Procalcitonin, requested by the treating physician at 
ED presentation for clinical reason, was measured using 
an automated Enzyme-Linked Fluorescent Assay (ELFA): 
VIDAS® B.R.A.H.M.S PCT™ (Vidas, BioMerieux). Sam-
ples were processed by personnel blinded from any 
patient data. We considered two PCT cut-off of 0.25 and 
0.5 ng/ml based on previous studies [6, 7, 10–12]. These 
studies suggested that a PCT level <0.25  ng/ml can be 
used to rule out bacterial pneumonia in patients with 
suspected respiratory tract infections and a PCT level 
>0.5 ng/ml is considered to rule in bacterial pneumonia 
and to support antibiotic therapy. Patients that didn’t 
consent or didn’t undergo LUS within the time limit were 
excluded from the study. Patients in which PCT was not 
requested in ED were also excluded.
Chest CT was performed by one Somatom Definition 
AS128 (Siemens, Erlangen, Germany), only for clini-
cal purposes independent from the study protocol. An 
expert radiologist, other than the attending radiolo-
gist and blinded to LUS and CXR results, reviewed the 
studies investigating one or more consolidations related 
to pneumonia, defined as homogeneous increase in 
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pulmonary parenchymal attenuation obscuring the 
margins of vessels and airway walls, with or without air 
bronchograms [13].
The final diagnoses of pneumonia were determined 
by two expert internal medicine physicians, blinded to 
CXR, LUS and PCT results, who independently reviewed 
all available clinical data including CT data and medical 
records for hospitalized patients. In case of discordance, 
a third senior physician adjudicated the diagnosis.
Statistical analysis
The sample size was calculated considering a prevalence 
of pneumonia of 50% among suspected patients in ED 
and a sensitivity of LUS for the diagnosis of pneumonia 
when chest CT was used as gold standard of 80% [8]. 
Wanting to prove that PCT increased the sensitivity of 
10% and considering a type I error of 5% and a power 
(1-ß) of 80%, it was estimated that this would require 
approximately 120 patients.
Data points are expressed as mean ±  standard devia-
tion (SD). The unpaired Student’s t test was used to com-
pare normally distributed data. Fisher’s exact test was 
used for the comparison of non-continuous variables 
expressed as proportions. p  <  0.05 indicates statistical 
significance. All  p values are two sided. The diagnostic 
performance of LUS, CXR and PCT and the combination 
of LUS and CXR with PCT was assessed by calculating 
sensitivity, specificity, positive predictive value, nega-
tive predictive value and likelihood ratios. The extended 
McNemar and the McNemar tests were used to evalu-
ate if there was a significant difference in the accuracy, 
sensitivities and specificities of LUS, CXR, PCT and the 
combination of imaging tests with PCT [14]. Receiver 
operating characteristic (ROC) curves were constructed 
to assess the sensitivity and specificity of white blood 
cells count (WBC), PCT and multivariable models to 
compare the ability of LUS and CXR combined with PCT 
to predict pneumonia. Calculations were performed by 
using SPSS statistical package (version 17.0; IBM).
Results
Baseline characteristics
A total of 308 patients with respiratory complains under-
went chest CT in the ED during the study period. Four 
patients did not consent to participate. In 19 patients 
LUS was not performed before chest CT or within 
the time limit. In 157 patients PCT was not requested 
by the attending emergency physician at presenta-
tion in the ED. Thus, 128 patients were included in the 
final analysis (Fig.  1). These patients had a mean age of 
70.7  ±  15.8  years (range 23–100) and 64 (50%) were 
female. Pneumonia was the final diagnosis in 61 patients 
(47.7%). The patients’ characteristics according to the 
presence or absence of pneumonia are shown in Table 1. 
Alternative diagnoses in patients without pneumonia are 
reported in Table 2.
Main results
Lung ultrasonography was feasible in all patients, but in 
11 cases (8.2%), included in the study, pulmonary exami-
nation was limited only to the anterior-lateral areas 
mainly due to uncooperative patients. LUS was posi-
tive for at least one consolidation in 60 patients (46.9%). 
Fifty-two (86.7%) out of 60 patients with positive LUS 
had a final diagnosis of pneumonia (Fig.  1). LUS was 
false positive in eight cases (6.2%) and false negative in 
nine patients (7%). In three out of nine (33%) false nega-
tive cases pulmonary examination was limited only to the 
anterior-lateral areas. The sensitivity and the specificity 
of LUS were 85.2% (95% CI 73.8–93%) and 88.1% (95% CI 
77.8–94.7%) respectively.
Procalcitonin median in patients with and with-
out pneumonia were 0.3 and 0.1  ng/ml respec-
tively (p  =  0.05). The sensitivity and the specificity of 
PCT  ≥  0.25  ng/ml were 73.8% (95% CI 61–84.2%) and 
47.8% (95% CI 35.4–60.3%) respectively, whereas the 
sensitivity and the specificity of PCT  >  0.5  ng/ml were 
42.6% (95% CI 30–55.9%) and 67.2% (95% CI 54.6–78.1%) 
respectively.
Chest radiography was performed with the patient in 
the up-right position in 29 (23%) cases. Thirty-seven out 
of 45 patients (82.2%) with positive CXR had a final diag-
nosis of pneumonia. CXR showed false positive examina-
tion in 8 (6.2%) patients and false negative examination in 
24 (18.7%) patients. The sensitivity and the specificity of 
CXR were 60.7% (95% CI 47.3–72.9%) and 88.1% (95% CI 
77.8–94.7%) respectively.
In 38 cases (29.7%) we observed the combination of 
negative LUS and negative PCT (<0.25  ng/ml). A false 
negative combination of LUS/PCT test was observed in 2 
cases (1.6%). In one of these two patients the final diagno-
sis was infective endocarditis and heart failure associated 
to pneumonia. The other patient had a final diagnosis 
of pneumonia complicated by heart failure and non-ST 
elevated myocardial infarction. The derived sensitivity of 
negative LUS/PCT test was 96.7% (95% CI 88.6–99.5%) 
with a significant superiority to LUS alone and PCT alone 
(p < 0.05 for both). Negative predictive value (NPV) and 
negative likelihood ratio (LR) were 94.7% (95% CI 88.2–
99.2%) and 0.06 (95% CI 0.02–0.24) respectively. In 24 
patients (18.8%) we observed the combination of positive 
LUS and positive PCT (>0.5  ng/ml). Out of these, four 
were false positive (3.1%). The derived specificity, positive 
predictive value (PPV) and positive LR were 94% (95% CI 
85.4–98.3%), 83.3% (95% CI 62.6–95.2%) and 5.49 (95% 
CI 1.99–15.17) respectively. Specificity of the LUS/PCT 
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Fig. 1 Characteristics of patients according to the presence or absence of pneumonia. LUS lung ultrasonography; PCT procalcitonin
Table 1 Characteristics of the study population according to final diagnosis
Data are given as no. (%) or mean ± standard deviation (SD)
SD standard deviation; SBP systolic blood pressure; PaO2 arterial oxygen pressure express in mmHg; FiO2 fraction of inspired oxygen; bpm beats/min; ED emergency 
department
Pneumonia (n = 61) No pneumonia (n = 67) p value
Mean age ± SD, y 69.8 ± 18.8 71.6 ± 12.6 0.51
Women 25 (41%) 39 (58.2) 0.076
Medical history of lung disease
Chronic obstructive pulmonary disease 7 (11.5) 10 (14.9) 0.611
Lung cancer 2 (3.3) 5 (7.5) 0.444
Heart failure 11 (18) 14 (20.9) 0.824
Previous pulmonary embolism 1 (1.6) 3 (4.5) 0.621
Signs and symptoms at presentation
Dyspnea 44 (72.1) 49 (73.1) 1
Cough 26 (42.6) 12 (31.6) 0.003
Pleuritic chest pain 8 (13.1) 8 (11.9) 1
Shock/hypotension 17 (27.9) 13 (19.4) 0.3
SBP ± SD, mmHg 121.7 ± 30.5 124.9 ± 37.3 0.6
Heart rate >100 bpm 42 (68.9) 30 (44.8) 0.008
Respiratory rate/min 26.1 ± 8.2 23.3 ± 6.8 0.2
PaO2/FiO2 ± SD 292.6 ± 83.9 309.5 ± 94 0.29
Temperature >37.8 °C 31 (50.8) 22 (32.8) 0.049
White blood cells count/mm3 12,494 ± 10,130.3 11,906 ± 6657 0.7
Mechanical invasive ventilation 4 (6.6) 6 (9) 0.747
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test was not significantly different when compared to 
LUS alone (p = 0.125).
In 46 patients (35.9%), CXR was negative for pneu-
monia and PCT was <0.25  ng/ml. False negative cases 
where 12 (9.4%). The derived sensitivity, NPV and nega-
tive LR were 80.3% (95% CI 68.1–89.4%), 73.9% (95% CI 
58.9–85.7%) and 0.39 (95% CI 0.22–0.68) respectively. 
In 16 patients (12.5%) CXR was positive for pneumo-
nia and PCT was >0.5 ng/ml (16, 12.5%), with one false 
positive case (0.8%). The derived specificity, PPV and 
positive LR were 98.5% (95% CI 91.9–99.7%), 93.7% 
(95% CI 69.7–98.9%) and 16.48 (95% CI 2.24–121.05%) 
respectively.
The sensitivity of negative LUS/PCT (<0.25  ng/ml) 
was significantly higher than negative CXR/PCT (96.7 vs 
80.3%, p < 0.05), whereas the specificity of positive LUS/
PCT (>0.5 ng/ml) was not significantly different to posi-
tive CXR/PCT (94 vs 98.5%, p = 0.68). Overall test char-
acteristics of LUS, CXR and PCT and of LUS and CXR 
combined with PCT are reported in Tables 3 and 4.
According to ROC curve, the diagnostic accuracy of 
LUS associated with PCT (88.8% ± 3.1) was higher than 
the total count of white blood cells (WBC) (49.1% ± 5.2), 
PCT alone (60.7%  ±  5) and CXR associated with PCT 
(77.4% ± 4.2) (Fig. 2).
Discussion
To our knowledge, this is the first study evaluating the 
diagnostic performance of LUS combined with PCT for 
the diagnosis of pneumonia in the ED. Research on the 
diagnosis of pneumonia is usually hampered by difficul-
ties in obtaining a systematic comparison with CT scan. 
The lack of a gold standard that supports the visual diag-
nosis of pneumonia, may lower the significance of many 
studies. One strength of our study is that the final diagno-
sis of pneumonia in all patients is supported by a post hoc 
review of the clinical chart, and based on the detection of 
typical consolidations at chest CT read by an expert radi-
ologist. In many previous studies LUS showed to be an 
accurate bedside tool for the diagnosis of pneumonia [8, 
15–17]. In our study LUS alone ruled in pneumonia with 
a good positive likelihood ratio and ruled out this condi-
tion with a moderate negative likelihood ratio. The supe-
riority of LUS over CXR is reported in literature [9]. In 
our study, despite the two methods showed similar spe-
cificities, the sensitivity of LUS was superior to CXR. We 
have to consider that in 8% of patients, pulmonary ultra-
sound examination was limited only to the anterior-lat-
eral areas and that 33% of all false negative cases belong 
to this group. In these patients, most dependent pulmo-
nary areas were not scanned and consolidations were not 
detected and this was the cause of a reduction in overall 
sensitivity of LUS for the diagnosis of pneumonia.
Procalcitonin is an emerging biomarker, whose practi-
cal application is increasingly common, not only in the 
diagnosis and follow-up of sepsis but also in pneumo-
nia [18]. A PCT value below the threshold level makes 
unlikely a severe pneumonia with bacteraemia and is 
used to withhold antibiotic therapy [19–21]. Müller et al. 
analysed data from two randomized prospective stud-
ies with a total of 545 patients with suspected infection 
of the lower respiratory tract. In their post-hoc analysis, 
they found that the diagnostic accuracy to predict radio-
graphically suspected community acquired pneumonia 
was significantly higher for PCT (87%) than for WBC 
(64%) [22]. In our study, the diagnostic accuracy of PCT, 
although inferior to the performance obtained by Müller 
et al., was still higher than WBC (49%).
Table 2 Final diagnosis in the study patients
Data are given as no. (%) unless otherwise indicated
Diagnosis No (%)
Pneumonia 61 (47.7)
Pulmonary embolism 21 (16.4)
Heart failure 9 (7)
Pleural effusion 8 (6.3)
Sepsis with no pulmonary involvement 8 (6.2)
Chronic obstructive pulmonary disease 4 (3.1)
Acute coronary syndrome 3 (2.3)
Tachyarrhythmia 1 (0.8)
Respiratory failure in pulmonary malignancy 1 (0.8)
Pericardial effusion/pericarditis 1 (0.8)
Miscellaneous 11 (8.6)
Table 3 Diagnostic performance of lung ultrasonography, chest radiograph and procalcitonin for the diagnosis of pneu-
monia
Sens sensitivity; Spec specificity; PPV positive predictive value; NPV negative predictive value; +LR positive likelihood ratio; −LR negative likelihood Ratio; 95% CI 95% 
confidence interval; CXR chest X-ray; LUS lung ultrasonography; PCT procalcitonin value express in ng/ml
Sens % (95% CI) Spec % (95% CI) PPV % (95% CI) NPV % (95% CI) +LR % (95% CI) −LR (95% CI)
LUS 85.2 (73.8–93) 88 (77.8–94.7) 86.7 (75.4–94) 86.8 (76.3–93.7) 7.14 (3.70–13.79) 0.17 (0.09–0.31)
CXR 60.7 (47.3–72.9) 88.1 (77.8–94.7) 82.2 (67.9–92) 71.1 (60.1–80.5) 5.08 (2.57–10.04) 0.45 (0.32–0.62)
PCT ≥ 0.25 73.8 (61–84.2) 47.8 (35.4–60.3) 56.2 (44.7–67.3) 66.7 (51.6–79.6) 1.41 (1.07–1.86) 0.55 (0.34–0.90)
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The lower accuracy of PCT found in our study com-
pared with the study by Müller may be due to a different 
selection of patients and to the different gold standard 
used for the diagnosis of pneumonia.
Despite its known role in the confirmation of bacte-
raemia in sepsis, in our study PCT alone was not suffi-
ciently accurate in the diagnosis of pneumonia. This can 
be explained considering that while the final diagnosis 
Table 4 Diagnostic performance of  lung ultrasonography and  chest radiograph combined with  procalcitonin for  the 
diagnosis of pneumonia
Sens sensitivity; Spec specificity; PPV positive predictive value; NPV negative predictive value; +LR positive likelihood ratio; −LR negative likelihood Ratio; 95% CI 95% 
confidence interval; CXR chest X-ray; LUS lung ultrasonography; PCT procalcitonin value express in ng/ml; or means that at least one test was positive; and means that 
both tests were positive
Sens % (95% CI) Spec % (95% CI) PPV % (95% CI) NPV % (95% CI) +LR (95% CI) −LR (95% CI)
Positive LUS or PCT ≥0.25 96.7 (88.6–99.5) 53.7 (41.1–66) 65.6 (54.8–75.3) 94.7 (82.2–99.2) 2.09 (1.61–2.72) 0.06 (0.02–0.24)
Positive LUS and PCT >0.5 32.8 (21.3–46) 94 (85.4–98.3) 83.3 (62.6–95.1) 60.6 (50.5–70) 5.49 (1.99–15.17) 0.71 (0.59–0.86)
Positive CXR or PCT ≥0.25 80.3 (68.1–89.4) 50.7 (38.2–63.2) 59.8 (48.3–70.4) 73.9 (58.9–85.7) 1.63 (1.2–2.1) 0.39 (0.22–0.68)












PCT plus CXR= 77.4±4.2
PCT plus LUS= 88.8±3.1
PCT plus CXR
PCT plus LUS
Fig. 2 ROC curve of WBC, PCT, LUS and CXR and their combination. WBC white blood cells; PCT procalcitonin; LUS lung ultrasonography; CXR chest 
X-ray
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of pneumonia was only confirmed in presence of typi-
cal clinical signs with at least one typical consolidation 
detected at chest CT, we cannot confirm that in our 
patients the radiologic consolidations were always due 
to a bacterial infection with bacteraemia. The major-
ity of patients with a final diagnosis of pneumonia were 
in a stable condition and showed an isolated pulmonary 
infection not necessarily associated with bacteraemia. It 
is well known that in cases of localized organ infections, 
PCT is usually lower as compared to septicaemia with 
positive blood cultures [23].
No previous studies evaluated the association of LUS and 
PCT for the bedside diagnosis of pneumonia in the ED. 
However, a recent study by Zagli et al. performed on criti-
cally ill patients in the intensive care unit, evaluated a new 
score, CEPPIS (chest echography and procalcitonin pul-
monary infection score), based on a combination of PCT 
and LUS for the diagnosis of ventilator associated pneu-
monia (VAP) [24]. The new proposed score differed from 
the traditional clinical pulmonary infection score (CPSI) 
basically in two items: WBC was replaced by PCT and 
CXR by LUS. The study showed that sensitivity of CEPPIS 
(80.5%) was superior then CPSI (39.8%) for the diagnosis 
of VAP, while specificity was similar (85.2 vs 83.3%). There 
are many methodological differences between the study of 
Zagli et al. and our study, but both showed that the sensi-
tivity of LUS/PCT is superior to other diagnostic approach 
based on CXR in the diagnosis of pneumonia.
In our study the association of a negative LUS examina-
tion with a PCT level <0.25 ng/ml significantly improved 
sensitivity of LUS for the diagnosis of pneumonia, 
reducing the occurrence of false negative diagnoses and 
decreasing the negative LR. We can argue that the clini-
cian, in approximately one-third of “difficult” diagnosis 
in patients with unexplained respiratory symptoms, may 
rule-out pneumonia with a sufficient level of certainty by 
combining LUS and PCT. On the other hand, our study 
showed that when LUS visualizes a consolidation with 
the typical ultrasonography features, the specificity and 
positive predictive value for the diagnosis of pneumonia 
is not significantly influenced by the addiction of PCT.
Lung ultrasonography is a powerful, cheap, easy to per-
form, and safe tool for the diagnosis of many pulmonary 
conditions at bedside and its use is exponentially increas-
ing among specialists and general practitioners in and out 
of hospitals. Moreover, the diagnostic accuracy of LUS 
for pneumonia is at least as good as CXR in different set-
tings and patients. Considering that a point-of care PCT 
measurement will become available for clinical practice 
[10], the results of this preliminary study opens new per-
spectives for improving the diagnostic approach to pneu-
monia at the bedside, by combining LUS and PCT in the 
general population. Further studies could also evaluate 
the usefulness of this combined diagnostic strategy in 
some subgroup of patients where CXR is less accurate or 
contraindicated such as bedridden patients in particular 
patients in invasive and not invasive ventilation, immu-
nocompromised patients and pregnant women. Further-
more, using multiple biomarkers combined with LUS 
could further increase diagnostic accuracy of physicians 
and be useful to triage patients at the bedside in many 
different clinical scenarios[25].
Study limitations
A questionable characteristic of our protocol is that 
patients were not enrolled on the basis of a direct sus-
picion for pneumonia. We concentrated our study on 
patients with respiratory complains, who demanded 
CT scan for ambiguous diagnosis. In case of suspected 
uncomplicated lung infection, where the diagnosis is 
mainly based on clinical findings and CXR, it is unu-
sual to undergo CT scans. Thus, our specific patient 
population does not allow generalization of our results. 
However, a systematic application of CT studies in all 
suspected low respiratory tract infection is not feasible 
because it does not represent a standard of care, and it 
is not ethical for its radiation burden and not sustainable 
for high cost. Another limitation of our study, is that the 
final diagnosis of pneumonia was based on the detec-
tion of a consolidation at chest CT, while the possibility 
of interstitial pneumonia was not considered. We have 
also to consider that it is not known if the consolidation 
identified at chest CT was due to bacterial, viral or other 
germ infection. Regarding the comparison between LUS 
and CXR, a consideration should be done on the crite-
ria of enrolment. In fact, the patients enrolled in the 
study underwent chest CT once the physician was aware 
of CXR results, and this could have selected a popula-
tion with not diagnostic CXR. Thus, this criteria prob-
ably affected the low sensitivity of CXR. However, in the 
real practice, the role of LUS is often to confirm negative 
chest films in patients with high suspicion of pneumonia. 
Thus, the difference in sensitivity between the two meth-
odologies is still confirmed. Indeed, the fact that in our 
study the majority of CXR were not performed in the up-
right position, may have influenced more significantly the 
comparison between the two methods. The anterior-pos-
terior radiographic view is undoubtedly less accurate for 
the study of the lungs. However, the evaluation of sub-
optimal chest films is largely representative of the real 
daily practice and the main cause of inconclusive CXR 
studies. Finally, the lack of systematic and consecutive 
PCT assays in the population studied may have biased 
our results. Indeed, a PCT assay was only based on the 
personal judgement of the attending physician facing 
challenging diagnostic situations and was independent 
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from the study protocol. However, these situations are 
exactly those deserving more accurate and sometimes 
alternative diagnostic tools, that is the possible future 
role of a combined LUS/PCT protocol.
Conclusions
The combination of LUS and PCT showed a high sensi-
tivity for the diagnosis of pneumonia in patients present-
ing with respiratory complaints of uncertain origin that 
underwent chest CT and the sensitivity of this combina-
tion was significantly higher when compared with the 
sensitivity of LUS alone and PCT alone.
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